Results

Date: 14th August 2026 Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Scrip Code: 542248 Subject: Outcome of Board Meeting- Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find enclosed herewith the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended 30.06.2026 along with Limited Review Report by Statutory Auditor i.e. Keyur Shah & Associates, Chartered Accountants. Further, the said outcome and results shall be uploaded on the website of the Company at www.deccanhealthcare.co.in The Meeting was commenced at 01:30 P.M. and concluded at 01:40 P.M. Kindly take this information on your record. Thanking You Your Faithfully, For Deccan Health Care Limited Shikha Das Company Secretary & Compliance Officer M. No A78917 Registered Office: Innovation Hub & Manufacturing: 6-3-347/17/5/A/Back Position, Plot No.13, Sector 03, IIE Pant Nagar, Dwarakapuri Colony, Punjagutta, SIDCUL, Udham Singh Nagar – 263153, Hyderabad – 500082, Telangana, India Uttarakhand, India Email: info@deccanhealthcare.co.in CIN: L72200TG1996PLC024351 Tel: +91 40 4709 6427 www.deccanhealthcare.co.in ~ ~1ur Shah &Associates CHARTERED ACCOUNTANTS CA Keyur Shah FCA, B.Com, ISA, FAFD Certified Limited Review Report on unaudited standalone financial results of Deccan Health care Limited for the Quarter ended 30th June, 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Usting Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors Of, Deccan Health care Umlted We have reviewed the accompanying the statement of unaudited Standalone financial results ("the financial statement") of Deccan Health care Umlted ("the Company'') for the Quarter ended on 30th June, 2026. The Financial Statement is the responsibility of the Company's Management and has been approved by the Board of Directors, has been prepared in accordance with recognition and measurement principles laid down as per accounting standard prescribed under section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in compliance with regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Our responsibility is to issue a report on the Statement based on our review. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410 "Review of Interim Financial Information performed by the independent Auditor of the Entity'', issued by the institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primary to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited Standalone financial results, prepared in accordance with applicable Indian Accounting standards ("Ind AS") and other recognized accounting practices and policies as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information require to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For, Keyur Shah & Associates Chartered Accoun ,..-:::==-... ... F.R. No. 333288 Akhlaq Ahmad Mu Partner M. No. 181329 Date: -14th August, 2026 UDIN: 261813291PECUV9325 Place: -Ahmedabad 303, Shitiratna, B/s. Radisson Blu Hotel, Nr. Panchvatl Circle, Ambawadi, Ahmedabad-380006. Gujarat, INDIA. Ph. : +91 79 48999595, M. : +9199984 30684 • Website : www.keyurshahca.com E-mail : keyur@keyurshahca.com, ca.keyurshah20l5@gmail.com DECCANH EALT H CAREL IMITED CIH•L72200TG1996PLC02◄351 6•3·3◄7/17/5/A/Back Position, Dwarkapurl Colony, PunJ81utta Hyderabad, TG • 500082 Standalone flnandal RHults for the Quarter Ended on 30th June, 2026 Rs. In Lakhs (unless otherwise stated) Sr. Quarter Ended YearE nded Particulars No. 30th June, 2026 31st March, 2026 30th June, 2025 31st March, 2026 Un-audited Audited Un-audited Audited Income From Operations a) Revenue from Operations 2,185.61 2,026.49 2,146.95 8,917.10 b) Other Income 2.57 0.08 0.62 0.87 Total Income 2,188.18 2,026.57 2, 1◄7.57 8,917.97 II Expenses a) Cost of Materials Consumed 2,2◄7.3◄ 1,658.80 1,905.21 6,292.◄5 b) Changes in Inventories of Finished Goods, Work-In-Progressa nd (7◄5.◄8) (339.63) (361.27) (227.5◄) Stock-In-Trade c) Employee Benefit Expense 120.6◄ 118.88 136.37 52◄.53 d) Finance Costs 15.61 1◄.33 1.71 36.61 e) Depreciation and Amortisation Expense 38.60 38.11 ◄0.55 1◄6.36 f) Other Expenses ◄78.68 511.30 39◄.89 1,839.98 Total Expenses 2,155.39 2,001.79 2, 117.◄6 8,612.39 II Profit/ (loss) Before Tax (1-11) 32.79 2◄.78 30.11 305.58 IV TaxE:xpense a) Current Tax 11.74 5.84 13.17 88.54 b) Deferred Tax (Asset)/Liabilitles (3.58) (3.81) (4.31) (12.00) Total Tax E:xpense 8.16 2.03 8.86 76.S◄ V twt Profit/ (loss) Aftff Tax f« the Period (Ill-IV) 2◄.63 22.75 21.25 229.0◄ VI Other Comprehensiw: Income/ (Loss) a) Items that will not be reclassified to Profit & Loss (Net Of Tax) (0.28) (12.54) 3.80 (1.13) b) Items that may be reclassified to Profit & Loss (Net Of Tax) Total Other Comprehensive Income/ (loss) (0.28) (12.5-4) 3.80 (1.13) vn Total Comprehensiw Income/ (Loss) f« the period f>/+ VI) 2◄.35 10.21 25.05 227.91 VIII Paidup Equity Share capital (Facevalue Rs 10 each) 2,◄7◄.92 2,◄7◄.92 2,◄7◄.92 2,◄7◄.92 IX Other Equity 8,5◄7.46 X Eaminp Per Equity Share- Basic/Diluted Basic 0.10 0.09 0.09 0.93 Diluted {After comersion CJwI wrMts) 0.10 0.09 0.09 0.93 DECCAHNE ALT HC AREL IMITED CIH-i.72200TG1996PLC024351 6-3•347/17/5/A/Back Position, DwarkapuriC olony, PunJ-.utt.aH yderabad,T G • 500012 Notes to Accounts -Standalone Flnanclal Statement [1) The above unaudited Standalone Financial Results of Deccan Health Care Limited for the Quarter Ended on 30th June, 2026 were reviewed and recommended by the Audit committee and approved by the Board of Direct<n, at their respective meeting held on 14th August, 2026. These results have been reviewed by the Statutory Auditors of the Company in terms of Regulation 33 of the Securities and Exchange Board of India (Usttng Obligations and Disclosure Requirements) Regulation, 2015 (LOOR) (as amended). [2J Pn!YiousY ear's /period's fig\n-5 have been rearouped/rearranged/ restated/adjusted/rectifled/recasted wherever considered necessary. [3) Basts of Preparation of the Statement and Adoption of Indian Accounting Standards. The Company has adopted Indian Accounting Standard (INDA S) specified under C0111)11nies( Indian) Accounttna Standard Rules, 2015 [as ammended) precribed under section 133 of the companies act,2013. l<CTJh e Company is eneaaefdn manufactunnc of nutraceutfcal products. Considering the nature of Business and Financial Reporting of the Company, the Company Is op«atinl fn only one Setment. Hence seemer,t reportine ts not applkable. (5) The fil\ire for the quarter ended 31st March, 2026 are balandll!I fttures between the audited figures in respect of year ended on 31st March, 2026 and the nine month fflCledf ltun!su pto the third quarter ended on 31st December, 2025. [6) The Status of investor"s complaints durill!I [Showing first 8,000 characters — download PDF for full document]